A detailed history of State Of Wisconsin Investment Board transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 76,491 shares of SANA stock, worth $126,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,491
Previous 127,176 39.85%
Holding current value
$126,210
Previous $694,000 54.18%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.76 - $6.86 $190,575 - $347,699
-50,685 Reduced 39.85%
76,491 $318,000
Q2 2024

Aug 14, 2024

BUY
$5.23 - $10.44 $128,114 - $255,738
24,496 Added 23.86%
127,176 $694,000
Q1 2024

May 14, 2024

SELL
$4.2 - $11.27 $47,019 - $126,167
-11,195 Reduced 9.83%
102,680 $1.03 Million
Q4 2023

Feb 12, 2024

SELL
$2.8 - $4.55 $185,822 - $301,960
-66,365 Reduced 36.82%
113,875 $464,000
Q3 2023

Nov 14, 2023

BUY
$3.77 - $6.23 $22,080 - $36,489
5,857 Added 3.36%
180,240 $697,000
Q2 2023

Aug 14, 2023

SELL
$3.22 - $7.53 $183,955 - $430,181
-57,129 Reduced 24.68%
174,383 $1.04 Million
Q1 2023

May 15, 2023

SELL
$3.11 - $4.92 $84,193 - $133,194
-27,072 Reduced 10.47%
231,512 $757,000
Q4 2022

Feb 14, 2023

BUY
$3.19 - $6.46 $322,413 - $652,912
101,070 Added 64.17%
258,584 $1.02 Million
Q3 2022

Nov 14, 2022

BUY
$5.58 - $9.04 $589,895 - $955,672
105,716 Added 204.09%
157,514 $945,000
Q2 2022

Aug 15, 2022

SELL
$4.12 - $9.35 $252,152 - $572,238
-61,202 Reduced 54.16%
51,798 $333,000
Q4 2021

Feb 11, 2022

BUY
$15.18 - $23.15 $1.19 Million - $1.81 Million
78,300 Added 225.65%
113,000 $1.75 Million
Q2 2021

Aug 12, 2021

BUY
$16.65 - $32.14 $577,755 - $1.12 Million
34,700 New
34,700 $682,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $314M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.